Capital Analysts LLC’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-3
Closed -$1K – 1336
2024
Q3
$1K Hold
3
– – ﹤0.01% 1267
2024
Q2
$1K Buy
+3
New +$1.01K ﹤0.01% 1154
2023
Q4
– Sell
-9
Closed -$4K – 1157
2023
Q3
$4K Buy
+9
New +$4.23K ﹤0.01% 994
2022
Q4
– Sell
-10
Closed -$5K – 1106
2022
Q3
$5K Buy
+10
New +$4.86K ﹤0.01% 886
2022
Q1
– Sell
-12
Closed -$6K – 979
2021
Q4
$6K Hold
12
– – ﹤0.01% 861
2021
Q3
$5K Buy
12
+5
+71% +$2.12K ﹤0.01% 855
2021
Q2
$3K Sell
7
-3
-30% -$1.31K ﹤0.01% 848
2021
Q1
$4K Buy
+10
New +$3.99K ﹤0.01% 890

Other funds holding HUM

Capital Analysts LLC's HUM Position: Q4 2024 in Review

Capital Analysts LLC sold out of Humana (HUM) in Q4 2024, closing a stake of 3 shares — an estimated $1K sold.

Capital Analysts LLC first reported a position in HUM in Q1 2021 and held it in 8 quarters. The position peaked at $6K in Q4 2021. 879 funds tracked by Wall St. Rank hold HUM as of Q4 2024.

  • Capital Analysts LLC reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
  • Capital Analysts LLC sold 3 Humana shares in Q4 2024, an estimated $1K.
  • Capital Analysts LLC first reported a position in Humana in Q1 2021 and held it in 8 quarters.
  • Capital Analysts LLC's Humana position peaked at $6K in Q4 2021.
  • 879 funds tracked by Wall St. Rank held Humana as of Q4 2024.

Based on Capital Analysts LLC's 13F filing for Q4 2024, filed 14 Feb 2025.